AAAAAA

   
Results: 1-13 |
Results: 13
CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology
Authors: Begolka, WS Haynes, LM Olson, JK Padilla, J Neville, KL Dal Canto, M Palma, J Kim, BS Miller, SD
Citation: Ws. Begolka et al., CD8-deficient SJL mice display enhanced susceptibility to Theiler's virus infection and increased demyelinating pathology, J NEUROVIRO, 7(5), 2001, pp. 409-420
Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice
Authors: Katz-Levy, Y Neville, KL Padilla, J Rahbe, S Begolka, WS Girvin, AM Olson, JK Vanderlugt, CL Miller, SD
Citation: Y. Katz-levy et al., Temporal development of autoreactive Th1 responses and endogenous presentation of self myelin epitopes by central nervous system-resident APCs in Theiler's virus-infected mice, J IMMUNOL, 165(9), 2000, pp. 5304-5314
Central nervous system chemokine expression during Theiler's virus-induceddemyelinating disease
Authors: Hoffman, LM Fife, BT Begolka, WS Miller, SD Karpus, WJ
Citation: Lm. Hoffman et al., Central nervous system chemokine expression during Theiler's virus-induceddemyelinating disease, J NEUROVIRO, 5(6), 1999, pp. 635-642
Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis
Authors: Begolka, WS Miller, SD
Citation: Ws. Begolka et Sd. Miller, Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis, RES IMMUNOL, 149(9), 1998, pp. 771-781
Antigen-driven regulation of experimental autoimmune encephalomyelitis - Discussion
Authors: Begolka, WS Miller, SD Segal, BM Racke, MK Lovett-Racke, AE
Citation: Ws. Begolka et al., Antigen-driven regulation of experimental autoimmune encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 842-843
Immune cell entry to the CNS - a focus for immunoregulation of EAE - Discussion
Authors: Segal, BM Willenborg, DO Racke, MK Lovett-Racke, AE Hoffman, LM Karpus, WJ Begolka, WS Miller, SD
Citation: Bm. Segal et al., Immune cell entry to the CNS - a focus for immunoregulation of EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 844-846
Chemokine regulation of CNS T-cell infiltration in experimental autoimmuneencephalomyelitis - Discussion
Authors: Owens, T Begolka, WS Miller, SD
Citation: T. Owens et al., Chemokine regulation of CNS T-cell infiltration in experimental autoimmuneencephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 846-847
Cytokines and antibodies in myelin oligodendrocyte glycoptotein-induced experimental allergic encephalomyelitis - Discussion
Authors: Willenborg, DO Owens, T Begolka, WS Miller, SD
Citation: Do. Willenborg et al., Cytokines and antibodies in myelin oligodendrocyte glycoptotein-induced experimental allergic encephalomyelitis - Discussion, RES IMMUNOL, 149(9), 1998, pp. 847-848
Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Discussion
Authors: Owens, T Segal, BM Racke, MK Lovett-Racke, AE Begolka, WS Miller, SD
Citation: T. Owens et al., Tumour necrosis factor-alpha and lymphotoxin-alpha in the pathology of experimental autoimmune encephalomyelitis: is either one responsible or is there another ligand-mediating disease? Discussion, RES IMMUNOL, 149(9), 1998, pp. 849-850
The comeback of the elusive "suppressor" cell: an update on the regulatorynetwork in EAE - Discussion
Authors: Begolka, WS Miller, SD Hoffman, LM Karpus, WJ Owens, T Racke, MK
Citation: Ws. Begolka et al., The comeback of the elusive "suppressor" cell: an update on the regulatorynetwork in EAE - Discussion, RES IMMUNOL, 149(9), 1998, pp. 850-851
Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur? Discussion
Authors: Hoffman, LM Karpus, WJ Owens, T Begolka, WS Miller, D
Citation: Lm. Hoffman et al., Bystander suppression in experimental autoimmune encephalomyelitis: where and how does it occur? Discussion, RES IMMUNOL, 149(9), 1998, pp. 851-852
TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein - Discussion
Authors: Segal, BM Owens, T Karpus, WJ Begolka, WS Miller, SD
Citation: Bm. Segal et al., TCR peptide-reactive T cells and peripheral tolerance to myelin basic protein - Discussion, RES IMMUNOL, 149(9), 1998, pp. 852-854
T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification - Discussion
Authors: Willenborg, DO Owens, T Segal, BM Begolka, WS Miller, SD
Citation: Do. Willenborg et al., T-cell design: optimizing the therapeutic potential of autoreactive T cells by genetic modification - Discussion, RES IMMUNOL, 149(9), 1998, pp. 854-855
Risultati: 1-13 |